Brief: Chimeric Therapeutics Announces A$6.6 Mln Placement
20/05/2025 02:27
May 20 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: A$6.6 MILLION PLACEMENT AT ISSUE PRICE OF A$0.004 PER SHARE Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial